111 related articles for article (PubMed ID: 31084432)
1. Tocotrienols Modulate Breast Cancer Secretomes and Affect Cancer-Signaling Pathways in MDA-MB-231 Cells: A Label-Free Quantitative Proteomic Analysis.
Ramdas P; Radhakrishnan AK; Abdu Sani AA; Abdul-Rahman PS
Nutr Cancer; 2019; 71(8):1263-1271. PubMed ID: 31084432
[TBL] [Abstract][Full Text] [Related]
2. Advancing the Role of Gamma-Tocotrienol as Proteasomes Inhibitor: A Quantitative Proteomic Analysis of MDA-MB-231 Human Breast Cancer Cells.
Ramdas P; Radhakrishnan AK; Abdu Sani AA; Kumari M; Anandha Rao JS; Abdul-Rahman PS
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877708
[TBL] [Abstract][Full Text] [Related]
3. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
4. Differential suppression of proliferation in MCF-7 and MDA-MB-231 breast cancer cells exposed to alpha-, gamma- and delta-tocotrienols is accompanied by altered expression of oxidative stress modulatory enzymes.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Oct; 30(10):4169-76. PubMed ID: 21036737
[TBL] [Abstract][Full Text] [Related]
5. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.
Nesaretnam K; Stephen R; Dils R; Darbre P
Lipids; 1998 May; 33(5):461-9. PubMed ID: 9625593
[TBL] [Abstract][Full Text] [Related]
6. Omega 3-DHA and Delta-Tocotrienol Modulate Lipid Droplet Biogenesis and Lipophagy in Breast Cancer Cells: the Impact in Cancer Aggressiveness.
Pizato N; Kiffer LFMV; Luzete BC; Assumpção JAF; Correa LH; Melo HAB; Sant'Ana LP; Ito MK; Magalhães KG
Nutrients; 2019 May; 11(6):. PubMed ID: 31141912
[TBL] [Abstract][Full Text] [Related]
7. The estrogen receptor β-PI3K/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson's disease model.
Nakaso K; Tajima N; Horikoshi Y; Nakasone M; Hanaki T; Kamizaki K; Matsura T
Biochim Biophys Acta; 2014 Sep; 1842(9):1303-12. PubMed ID: 24768803
[TBL] [Abstract][Full Text] [Related]
8. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
[TBL] [Abstract][Full Text] [Related]
9. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
Tilli TM; Carels N; Tuszynski JA; Pasdar M
Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
[TBL] [Abstract][Full Text] [Related]
10. SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: the secreted lactoferrin and the intracellular delta-lactoferrin.
Hoedt E; Chaoui K; Huvent I; Mariller C; Monsarrat B; Burlet-Schiltz O; Pierce A
PLoS One; 2014; 9(8):e104563. PubMed ID: 25116916
[TBL] [Abstract][Full Text] [Related]
11. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination.
Guthrie N; Gapor A; Chambers AF; Carroll KK
J Nutr; 1997 Mar; 127(3):544S-548S. PubMed ID: 9082043
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis Reveals That an Extract of the Plant Lippia origanoides Suppresses Mitochondrial Metabolism in Triple-Negative Breast Cancer Cells.
Raman V; Aryal UK; Hedrick V; Ferreira RM; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
J Proteome Res; 2018 Oct; 17(10):3370-3383. PubMed ID: 30185032
[TBL] [Abstract][Full Text] [Related]
14. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
[TBL] [Abstract][Full Text] [Related]
15. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienols inhibited growth and induced apoptosis in human HeLa cells through the cell cycle signaling pathway.
Wu SJ; Ng LT
Integr Cancer Ther; 2010 Mar; 9(1):66-72. PubMed ID: 20150225
[TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action.
Mezquita B; Mezquita P; Pau M; Gasa L; Navarro L; Samitier M; Pons M; Mezquita C
Sci Rep; 2018 May; 8(1):7047. PubMed ID: 29728589
[TBL] [Abstract][Full Text] [Related]
18. Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
Sánchez-Bailón MP; Calcabrini A; Mayoral-Varo V; Molinari A; Wagner KU; Losada JP; Ciordia S; Albar JP; Martín-Pérez J
Oncotarget; 2015 May; 6(15):13520-38. PubMed ID: 25980494
[TBL] [Abstract][Full Text] [Related]
19. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
Sylvester PW; Ayoub NM
Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of proteins engaged in α-methylene-δ-lactone cytotoxic effects in hormone-independent breast cancer MDA-MB-231 cells.
Wyrebska A; Pawlowska Z; Gach K; Komorowski P; Protas A; Walkowiak B; Janecka A
Chem Biol Drug Des; 2014 Sep; 84(3):300-6. PubMed ID: 24618086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
